CS logo
small CS logo
UT Medical Group

Memphis, Tennessee, United States

About UT Medical Group


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at UT Medical Group


During the past decade, UT Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "UT Medical Group" #1 sponsor was "Aldeyra Therapeutics, Inc." with 1 trials, followed by "Apellis Pharmaceuticals, Inc." with 1 trials sponsored, "Cephalon" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UT Medical Group" #1 collaborator was "Otsuka America Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at UT Medical Group


According to Clinical.Site data, the most researched conditions in "UT Medical Group" are "ADHD" (1 trials), "Alzheimer's Disease" (1 trials), "Autistic Disorder" (1 trials), "Benign Prostatic Hypertrophy" (1 trials) and "C3 Glomerulonephritis" (1 trials). Many other conditions were trialed in "UT Medical Group" in a lesser frequency.

Clinical Trials Intervention Types at UT Medical Group


Most popular intervention types in "UT Medical Group" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "AC-3933" (1 trials), "APL-2" (1 trials), "Alfuzosin (SL770499)" (1 trials) and "Aripiprazole" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UT Medical Group


The vast majority of trials in "UT Medical Group" are 6 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at UT Medical Group


Currently, there are NaN active trials in "UT Medical Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UT Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UT Medical Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".